Skip to main content

RDY 353 Pill - brown capsule/oblong, 17mm

Pill with imprint RDY 353 is Brown, Capsule/Oblong and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Dr. Reddy's Laboratories Ltd.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 353

Rivastigmine tartrate 3 mg RDY 353

Rivastigmine Tartrate

RDY 353
3 mg
17.00 mm
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
Inactive Ingredients
silicon dioxide, hypromellose 2910 (5 mPa.s), magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferrosoferric oxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.